重點成果

重點成果

• 
  2021-03-26 重點成果

  Development of biotinylated and magnetic bead-immobilized enzymes for efficient glyco-engineering and isolation of antibodies

  吳宗益
  Bioorganic Chemistry

• 
  2021-03-03 重點成果

  Characterization of initial key steps of IL-17 receptor B oncogenic signaling for targeted therapy of pancreatic cancer

  李文華
  Science Translational Medicine

• 
  2021-03-03 重點成果

  Decoy Receptor 3 Inhibits Monosodium Urate-Induced NLRP3 Inflammasome Activation via Reduction of Reactive Oxygen Species Production and Lysosomal Rupture

  謝世良
  Frontiers in immunology

• 
  2021-03-03 重點成果

  Hepatocellular Carcinoma Prediction Models in Chronic Hepatitis B: A Systematic Review of 14 Models and External Validation

  楊懷壹
  Clinical Gastroenterology and Hepatology

• 
  2021-02-26 重點成果

  Practical Remdesivir Synthesis through One-Pot Organo-Catalyzed Asymmetric (S)-P-Phosphoramidation

  洪上程, 翁啟惠
  JOC

• 
  2021-02-18 重點成果

  Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection

  謝世良
  Communications Biology

• 
  2021-02-18 重點成果

  Editorial: incorporating liver stiffness to risk scores for HCC in patients with chronic hepatitis B treated with oral antivirals: ready to use or not?

  楊懷壹
  Aliment Pharmacol Ther

• 
  2021-02-02 重點成果

  Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection

  馬徹, 洪上程, 翁啟惠
  PNAS

• 
  2021-01-19 重點成果

  Interplay between desmoglein2 and hypoxia controls metastasis in breast cancer

  黃雯華
  PNAS

• 
  2021-01-16 重點成果

  Natural History and Hepatocellular Carcinoma Risk in Untreated Chronic Hepatitis B Patients With Indeterminate Phase

  楊懷壹
  Clinical Gastroenterology and Hepatology